$3.57 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 7 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| G | GENPACT LIMITED | $1,241,280,000 | +5.8% | 40,538,196 | 0.0% | 34.78% | +4.7% | |
| MIK | MICHAELS COS INC | $856,927,000 | -15.3% | 52,798,929 | 0.0% | 24.01% | -16.3% | |
| IQV | IQVIA HLDGS INC | $495,037,000 | +30.0% | 3,815,315 | 0.0% | 13.87% | +28.5% | |
| SGRY | SURGERY PARTNERS INC | $436,518,000 | +10.7% | 26,455,651 | 0.0% | 12.23% | +9.5% | |
| ATTO | ATENTO S A | $363,905,000 | +9.5% | 48,520,671 | 0.0% | 10.20% | +8.3% | |
| VRTV | Sell | VERITIV CORP | $101,332,000 | -40.6% | 2,783,840 | -35.0% | 2.84% | -41.3% |
| FI | FRANKS INTL N V | $73,798,000 | +11.2% | 8,506,930 | 0.0% | 2.07% | +10.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners X, L.P. #1
- Bain Capital Fund X, L.P. #2
- Bain Capital Integral Investors 2008, L.P. #3
- Bain Capital Partners Europe III, L.P. #4
- Bain Capital Europe Fund III, L.P. #5
- Bain Capital Partners VII, L.P. #6
- Bain Capital Fund VII, L.P. #7
- Bain Capital VII Coinvestment Fund, L.P. #8
- UWW Holdings, LLC #9
- Bain Capital Integral Investors 2006, LLC #10
- Bain Capital Partners Asia II, L.P. #11
- Glory Investments A Limited #12
- Glory Investments B Limited #13
- Atalaya Luxco S.a.r.l. #14
- Atalaya Luxco Topco S.C.A. #15
- Atalaya PIKco S.a.r.l. #16
- Atalaya Luxco PIKco SCA #17
- Bain Capital Partners VIII, L.P. #18
- Bain Capital Fund VIII, L.P. #19
- Bain Capital Fund VIII, LLC #20
- BC Brightness SPV GP, LLC #21
- BC Brightness SPV, LP #22
- BCPE Seminole GP LLC #23
- BCPE Seminole Holdings LP #24
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-21 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-18 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-06 |
| 4 | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.